Advances in Therapy

, Volume 22, Issue 2, pp 87–95 | Cite as

AIP: A proposed mechanism for evaluating adherence improvement initiatives

  • David Day


Pharmacy prescription databases are useful for determining rates of adherence to long-term medication therapy. Thus far, however, analyses based on such databases have provided only snapshots of adherence rates over discrete time intervals and have been of limited usefulness for the timely measurement of adherence trends when adherence improvement strategies change over time. The Adherence Index of Performance is new mechanism that can be used to monitor pharmacy prescription databases over time to detect changes that occur when adherence improvement strategies are changed during a therapeutic period.


adherence AIP drugs medication pharmacy prescription 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Taneja N, Wiegmann DA. The role of perception in medication errors: implications for nontechnological interventions.MJAFI. 2004;60:172–176.Google Scholar
  2. 2.
    Donovan JL. Patient decision making: the missing ingredient in compliance research.Int J Technol AssessHealth Care. 1995;11:443–455.PubMedCrossRefGoogle Scholar
  3. 3.
    Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review.J Clin Pharm Ther. 2001;26:331–342.PubMedCrossRefGoogle Scholar
  4. 4.
    TenHave TR, Coyne J, Salzer M, Katz I. Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial.Gen Hosp Psychiatry. 2003;25:115–123.PubMedCrossRefGoogle Scholar
  5. 5.
    Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines.Br J Gen Pract. 1990;40:114–116.PubMedGoogle Scholar
  6. 6.
    Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals.Circulation. 1997;95:1085–1090.PubMedGoogle Scholar
  7. 7.
    Hughes CM. Medication non-adherence in the elderly: how big is the problem?Drugs Aging. 2004;21:793–811.PubMedCrossRefGoogle Scholar
  8. 8.
    Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients.JAMA. 2002;288:455–461.PubMedCrossRefGoogle Scholar
  9. 9.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB. Antihypertensive persistence and drug class.Can J Cardiol. 2002;18:649–656.PubMedGoogle Scholar
  10. 10.
    Day D. Use of pharmacy claims databases to determine rates of medication adherence.Adv Ther. 2003;20:164–176.PubMedGoogle Scholar
  11. 11.
    Wogen J, Kreilick CA, Livornese RC, Yokoyama K, Frech F. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting.J Manag Care Pharm. 2003;9:424–429.PubMedGoogle Scholar
  12. 12.
    Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents?Am J Psychiatry. 2002;159:103–108.PubMedCrossRefGoogle Scholar
  13. 13.
    Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem?Ann Allergy Asthma Immunol. 1997;79:177–185.PubMedCrossRefGoogle Scholar
  14. 14.
    Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors.Ann Intern Med. 2001;134:968–977.PubMedGoogle Scholar
  15. 15.
    Weilburg JB, O’Leary KM, Meigs JB, Hennen J, Stafford RS. Evaluation of the adequacy of outpatient antidepressant treatment.Psychiatr Serv. 2003;54:1233–1239.PubMedCrossRefGoogle Scholar
  16. 16.
    Gilbody SM, House AO, Sheldon TA. Outcomes research in mental health: systematic review.Br J Psychiatry. 2002;181:8–16.PubMedCrossRefGoogle Scholar
  17. 17.
    Rand CS. Adherence to asthma therapy in the preschool child.Allergy. 2002;57(suppl 74):48–57.PubMedCrossRefGoogle Scholar
  18. 18.
    Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes.JAMA. 2002;288:462–467.PubMedCrossRefGoogle Scholar
  19. 19.
    Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a crossnational study.JAMA. 1998;279:1458–1462.PubMedCrossRefGoogle Scholar
  20. 20.
    McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review.JAMA. 2002;288:2868–2879.PubMedCrossRefGoogle Scholar
  21. 21.
    Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials.Arch Intern Med. 2004;164:722–732.PubMedCrossRefGoogle Scholar
  22. 22.
    Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA. Measuring adherence to behavioral and medical interventions.Control Clin Trials. 2000;21(suppl):188S-194S.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science and Business Media and LLC 2005

Authors and Affiliations

  • David Day
    • 1
  1. 1.Clinical ApplicationsPfizer Pharmaceuticals GroupNew York

Personalised recommendations